|Bid||68.70 x 900|
|Ask||68.76 x 800|
|Day's Range||68.34 - 69.06|
|52 Week Range||63.92 - 88.78|
|Beta (5Y Monthly)||0.66|
|PE Ratio (TTM)||75.11|
|Forward Dividend & Yield||0.21 (0.30%)|
|Ex-Dividend Date||May 03, 2022|
|1y Target Est||85.83|
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
GENEVA, August 09, 2022--Alcon Reports Second Quarter 2022 Results
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.